Deloitte in the news
Measuring the return from pharmaceutical innovation 2014
The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.
US Life Sciences Sector Leader
1700 Market St.
Homi, Vice Chairman at Deloitte LLP, has 30 years of experience with life sciences, consumer business, and process industry clients. As the National Life Sciences Leader, he leads Deloitte's life sciences practice that provides audit, consulting, enterprise risk, financial advisory, and tax services to pharmaceutical, biotechnology, medical technology, and consumer health care clients. Homi has also served on the Board of Directors for Deloitte LLP and the Consulting Executive Committee.